Health ❯ Obesity

Weight Loss Drugs

Semaglutide Wegovy FDA Approval Drug Comparison Tirzepatide Mechanism of Action Medicare Coverage Medicare Patients GLP-1 New Drugs Future Drugs Clinical Trials Pharmaceutical Competition Market Trends GLP-1 Agonists Pharmaceuticals

Eli Lilly Briefly Hits $1 Trillion, First Drugmaker to Reach the Milestone

Explosive tirzepatide sales recalibrated investor expectations for Lilly’s long-term growth.